Targeting programmed cell death in neurodegenerative diseases.
about
Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal systemStructural changes in the BH3 domain of SOUL protein upon interaction with the anti-apoptotic protein Bcl-xLThe role of oxidative stress in Parkinson's diseaseThe Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegenerationCell biology in neuroscience: Death of developing neurons: new insights and implications for connectivityInhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's diseaseGraphene: The Missing Piece for Cancer Diagnosis?Mitochondrial biology and Parkinson's diseaseEarly and Late Pathogenic Events of Newborn Mice Encephalitis Experimentally Induced by Itacaiunas and Curionópolis Bracorhabdoviruses InfectionGuanosine: a Neuromodulator with Therapeutic Potential in Brain DisordersEpigenetic Changes in Neurodegenerative DiseasesBiology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorderCHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonismLive imaging of apoptotic cells in zebrafish.Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo.Increased tau phosphorylation on mitogen-activated protein kinase consensus sites and cognitive decline in transgenic models for Alzheimer's disease and FTDP-17: evidence for distinct molecular processes underlying tau abnormalitiesReal-time imaging of single nerve cell apoptosis in retinal neurodegeneration.Spatial distribution of Parkinson's disease mortality in Spain, 1989-1998, as a guide for focused aetiological research or health-care interventionc-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis.No widespread induction of cell death genes occurs in pure motoneurons in an amyotrophic lateral sclerosis mouse model.Neuroanatomical phenotyping in the mouse: the dopaminergic system.Assessment of rat and mouse RGC apoptosis imaging in vivo with different scanning laser ophthalmoscopesInvolvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neuronsAn Overview of the Protective Effects of Chitosan and Acetylated Chitosan Oligosaccharides against Neuronal Disorders.In vitro and in vivo enhanced generation of human A9 dopamine neurons from neural stem cells by Bcl-XLThe antiapoptotic activity of melatonin in neurodegenerative diseases.A semi-automated technique for labeling and counting of apoptosing retinal cells.Mitochondrial dysfunction in the striatum of aged chronic mouse model of Parkinson's disease.Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivationThe crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model.Neuroprotective properties of chitosan and its derivatives.N-acetylcysteine attenuates hexavalent chromium-induced hypersensitivity through inhibition of cell death, ROS-related signaling and cytokine expression.Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damageUrate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease.Anti-amyloidogenic and anti-apoptotic role of melatonin in Alzheimer diseaseMeclizine is neuroprotective in models of Huntington's disease.The JNK- and AKT/GSK3β- signaling pathways converge to regulate Puma induction and neuronal apoptosis induced by trophic factor deprivationCathepsin deficiency as a model for neuronal ceroid lipofuscinoses.Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration.
P2860
Q21090220-545E2285-0132-4738-A2E4-10EB3B62DC2FQ24305408-99CE39F1-9D16-4FDD-ABD8-27257809ACCCQ24307946-9A16E584-F87F-41F2-96B1-830D862FE4FBQ24322927-5C3A6960-AD52-4A84-9767-6B65D91359A3Q24601046-CBAB9207-1C1D-417B-BE47-B7936AB73D3FQ24609725-4ADB205E-29CB-40F2-909A-AC2AEDECB793Q26775114-ADFEEA0D-77B2-4896-B686-51FC024F4D2DQ26824090-E7AB0F1C-3518-4877-A762-35FFF010C0EEQ27485432-64ABA118-F36C-485C-9429-ED90BAC17042Q28072158-BC34CA78-D658-464C-9C3A-433DA10AA49EQ28075559-C5006A50-C14F-4404-8AA6-F5449A0CA465Q28392275-AED7BB0D-D590-4FBE-A123-4EBB587CFFDCQ28579022-91DC7033-2D1D-4EFF-B490-94A69ED4CCB6Q30497270-87235E26-3A6E-4BA2-A6FF-6143F6B3439EQ30498073-8060AC35-402C-48A4-A7E0-2C8CD6770939Q30500257-661A02BF-F5D9-4F5F-8CA6-532CEC100781Q30832375-088A9C75-EF41-4625-B88A-BBF9275969B4Q30939826-A4705AAD-7173-4395-90C0-75F69F755F6CQ31104448-7B616D6A-D8E0-4F29-9F38-ECC6AC46C22FQ33224176-2E96D324-ED66-4CBF-96BA-1BBC81052247Q33227606-E466333E-E1EA-413F-A1CB-0DCC8942799BQ33304015-1500221E-A817-4F38-8471-055D50FFD7E9Q33442821-7BB54090-8202-472D-AA0D-65F54E206104Q33612147-162A07EE-EC07-4503-A19B-471A76FC3A40Q33744707-4257047D-C1D6-4676-9988-E4D7EF1C0A9DQ33757816-2FA4BC11-C489-4342-B4D4-DB888840AD63Q33778666-5A740D55-15CB-4C83-A145-E4DA9FB5EADEQ33868426-26864FBB-42A8-4B09-9900-D34CA7DCDF1BQ33931283-133234E6-2674-45B0-853A-19F91B6968C6Q34044497-F52E4840-78E1-4894-9273-A859FAE0ABC3Q34052467-B37BCC31-57A5-4881-A05F-9C8EC7E6A4DDQ34061851-DDFEFED0-8F20-443A-8280-CEC8F58E4E1FQ34233104-933D5098-86FC-46F2-A7A5-C3ABAEFD7931Q34245037-F80831D6-8E6A-4F60-B28D-D62C61B1E91DQ34273978-5955CB41-E90D-41A2-9407-70FCCE4EF666Q34402167-75236267-CAA2-415F-8DE0-E757A46D8616Q34424265-FC9B7016-22DE-44A5-BA49-82BE3970FB90Q34442409-DA80845D-1D29-400E-92B0-697ACE543A01Q34562951-EC914A1F-AD9F-4923-A306-01AF38274EF7Q34583071-80C8C229-951D-4E56-AF15-11635713358F
P2860
Targeting programmed cell death in neurodegenerative diseases.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Targeting programmed cell death in neurodegenerative diseases.
@ast
Targeting programmed cell death in neurodegenerative diseases.
@en
type
label
Targeting programmed cell death in neurodegenerative diseases.
@ast
Targeting programmed cell death in neurodegenerative diseases.
@en
prefLabel
Targeting programmed cell death in neurodegenerative diseases.
@ast
Targeting programmed cell death in neurodegenerative diseases.
@en
P356
P1476
Targeting programmed cell death in neurodegenerative diseases.
@en
P2093
Miquel Vila
P2888
P304
P356
10.1038/NRN1100
P407
P577
2003-05-01T00:00:00Z
P5875
P6179
1004087581